PCS-2023 > 3 > 3E > 3E0 > 3E07 |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E07 | Introduction, Coronary Artery | |
3E070 | Open | |
3E0701 | Thrombolytic | |
3E07016 | Introduction of Recombinant Human-activated Protein C into Coronary Artery, Open | |
3E07017 | Introduction of Other Thrombolytic into Coronary Artery, Open Approach | |
3E070G | Other Therapeutic Substance | |
3E070GC | Introduction of Other Therapeutic Substance into Coronary Artery, Open Approach | |
3E070K | Other Diagnostic Substance | |
3E070KZ | Introduction of Other Diagnostic Substance into Coronary Artery, Open Approach | |
3E070P | Platelet Inhibitor | |
3E070PZ | Introduction of Platelet Inhibitor into Coronary Artery, Open Approach | |
3E073 | Percutaneous | |
3E0731 | Thrombolytic | |
3E07316 | Introduction of Recombinant Human-activated Protein C into Coronary Artery, Percutaneous | |
3E07317 | Introduction of Other Thrombolytic into Coronary Artery, Percutaneous Approach | |
3E073G | Other Therapeutic Substance | |
3E073GC | Introduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Approach | |
3E073K | Other Diagnostic Substance | |
3E073KZ | Introduction of Other Diagnostic Substance into Coronary Artery, Percutaneous Approach | |
3E073P | Platelet Inhibitor | |
3E073PZ | Introduction of Platelet Inhibitor into Coronary Artery, Percutaneous Approach | |
3E074 | Percutaneous Endoscopic | |
3E074G | Other Therapeutic Substance | |
3E074GC | Introduction of Other Therapeutic Substance into Coronary Artery, Percutaneous Endoscopic Approach |
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |